PixCell Medical Partners with Healthcare Giants Medline, Henry Schein, and Fisher Scientific to Distribute HemoScreen Point of Care CBC Analyzer Across the USA
The partnership with Henry Schein, a global leader in healthcare solutions, will leverage the company's extensive distribution network to make the HemoScreen analyzer readily available to healthcare professionals nationwide.
- The partnership with Henry Schein, a global leader in healthcare solutions, will leverage the company's extensive distribution network to make the HemoScreen analyzer readily available to healthcare professionals nationwide.
- Additionally, Thermo Fisher Scientific, renowned for its scientific expertise and comprehensive product offerings, will contribute to broadening the reach of the HemoScreen analyzer within the scientific research and laboratory community.
- "We are thrilled to join forces with Henry Schein, Medline, and Thermo Fisher Scientific to bring the HemoScreen point-of-care CBC analyzer to healthcare providers and laboratories throughout the United States," said Guy Frak, CCO of PixCell Medical.
- Through these collaborations, PixCell Medical remains dedicated to advancing healthcare delivery by making cutting-edge diagnostic technology accessible and affordable across diverse healthcare settings.